Trichomonas vaginalis is one of four protozoan species of the family Trichomonadidae known to parasitize humans. Members of this family are characterized by their variable morphology, being spheroid or ovoid in form in axenic culture, but assuming an ameboid shape on contact with other cells (4, 101). Trichomonads reproduce by longitudinal binary fi ssion and lack a cystic stage, although large, round “pseudocysts” have been known to form under unfavorable conditions. All Trichomonadidae possess fi ve anterior fl agella, four of which are free moving. The fi fth recumbent fl agellum is anchored along the organism as a part of the undulating membrane. This membrane extends along at least half the length of the organism, and is supported by a noncontractile costa. Motility, described as “bobbing” or “quivering”, is characteristic of this family of organisms (38, 39).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ackers, J. P. (1990) Immunologic aspects of human trichomoniasis, in Trichomonads parasitic in humans (Honigberg, B. M., ed.), Springer, New York, NY, pp. 36–52.
Alderete, J. F. and Provenzano, D. (1997) The vagina has reducing environment sufficient for activation of Trichomonas vaginalis cysteine proteinases. Genitourin. Med. 73, 291–296.
Alper, M. M., Barwin, B. N., McLean, W. M., McGilveray, I. J., and Sved, S. (1985) Systemic absorption of metronidazole by the vaginal route. Obstet. Gynecol. 65(6), 781–784.
Arroyo, R., Gonzalez-Robles, A., Martinez-Palomo, A., and Alderete, J. F. (1993) Signalling of Trichomonas vaginalis for amoeboid transformation and adhesion synthesis follows cytoadherence. Mol. Microbiol. 7, 299–309.
Beach, D. H., Holz, G. G. Jr., Singh, B. N., and Lindmark, D. G. (1990) Fatty acid and sterol metabolism of Trichomonas vaginalis and Tritrichomonas foetus. Mol. Biochem. Parasitol. 38, 175–190.
Bouma, M., Snowdon, J. D., Fairlamb, A. H., and Ackers, J. P. (1998) Activity of disulfiram ((bis)diethylthiocarbamoyl)disulphide) and didiocarb (diethyldithiocarbamate) against metronidazole sensitive and resistant Trichomonas vaginalis and Tritrichomonas foetus. J. Antimicrob. Chemother. 42, 817–820.
Bramley, M. and Kinghorn, G. (1979) Do oral contraceptives inhibit Trichomonas vaginalis? Sex. Transm. Dis. 6, 261–263.
Cameron, D. E. and Padian, N. S. (1990) Sexual transmission of HIV and the epidemiology of other sexually transmitted diseases. AIDS 4(Suppl 1), S99–S103.
Campero, C. M., Hirst, R. G., Ladds, P. W., Vaughn, J. A., Emery, D. L., and Watson, D. L. (1990) Measurement of antibody in serum and genital fluids of bulls with ELISA after vaccination and challenge with Tritrichomonas foetus. Aust. Vet. J. 67(5), 175–178.
Carney, J. A., Unadkat, P., Yule, A., et al. (1988) A rapid agglutination test for the diagnosis of Trichomonas vaginalis infection. J. Clin. Pathol. 41, 806–808.
Caro-Paton, T., Carvajal, A., Diego, I. M., Martin-Arias, L. H., Requejo, A. A., and Pinilla, E. R. (1997) Is metronidazole tera-togenic? A meta-analysis. Br. J. Clin. Pharmacol. 44, 179–182.
Chen, K. C., Amsel, R., Eschenbach, D. A., and Holmes, K. K. (1982) Biochemical diagnosis of vaginitis: determination of diamines in vaginal fluid. J. Infect. Dis. 145, 337–345.
Chen, M. Y., Smith, N. A., Fox, E. F., Bingham, J. S., and Barlow, D. (2001) Acetarsol pessaries in the treatment of metronidazole-resist-ant Trichomonas vaginalis. Int. J. STD AIDS 10, 277–280.
Cleveland, L. R. (1928) Tritrichomonas fecalis nov. sp. of man; its ability to grow and multiply indefinitely in faeces diluted with tap water and in frogs and tadpoles. Am. J. Hyg. 8, 232–255.
Conner, T. H., Stoeckel, M., Evrard, J., and Legator, M. S. (1977) The contribution of metronidazole and two metabolites to the mutagenic activity detected in the urine in treated humans and mice. Cancer Res. 37, 629–633.
Cosar, C. and Julou, L. (1959) Activity of 1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole (8823 RP) against experimental Trichomonas vaginalis infection. Ann. Inst. Pasteur. 96, 238–241.
Crowell, A. L., Stephens, C. E., Kumar, A., Boykin, D. W., and Secor, W. E. (2004) Activities of dicationic compounds against Trichomonas vaginalis. Antimicrob. Agents Chemother. 48(9), 3602–3605.
Cunningham, F. E., Kraus, D. M., Brubaker, L., and Fischer, J. H. (1994) Pharmacokinetics of intravaginal metronidazole gel. J. Clin. Pharmacol. 34, 1060–1065.
Czeizel, A. E. and Rockenbauer, M. (1998) A population based case — control teratologic study of oral metronidazole treatment during pregnancy. Br. J. Obstet. Gynecol. 105, 322–327.
Dobell, C. C. (1939) The common flagellate of the human mouth, Trichomonas tenax (O.F.M.): its discovery and its nomenclature. Parasitology 31, 13–146.
Dubini, F., Riviera, L., Cocuzza, C., and Bellotti, M. G. (1992) Antibacterial, antimycotic, and trichomonicidal activity of a new nitroimidazole (EU 11100). J. Chemother. 4(6), 342–346.
Dunne, R. L., Dunne, L. A., Upcroft, P., O'Donoghue, P. J., and Upcroft, J. A. (2003) Drug resistance in the sexually transmitted parasitic protozoan Trichomonas vaginalis. Cell Res. 13(4), 239–249.
Edwards, D. I. (1980) Mechanisms of selective toxicity of met-ronidazole and other nitroimidazole drugs. Br. J. Vener. Dis. 56, 285–290.
Edwards, D. I. (1993) Nitroimidazole drugs — action and resistance mechanisms. I. Mechanisms of action. J. Antimicrob. Chemother. 31, 9–20.
Ellis, J. E., Yartlett, N., Cole, D., Humphreys, M. J., and Lloyd, D. (1994) Antioxidant defences in the microaerophilic protozoan Trichomonas vaginalis: comparison of metronidazole-resistant and sensitive strains. Microbiology 140, 2489–2494.
Fouts, A. C. and Kraus, S. J. (1980) Trichomonas vaginalis: a re-evaluation of its clinical presentation and laboratory diagnosis. J. Infect. Dis. 141, 137–143.
Gallai, Z. and Sylvestre, L. (1966) The present status of urogential trichomoniasis: a general review of the literature. Appl. Ther. 8, 773–778.
Gerbase, A. C., Rowley, J. T., Heymann, D. H., Berkeley, S. B. F., and Piot, P. (1998) Global prevalence and incidence estimates of selected curable STDs. Sex. Transm. Dis. 74(Suppl 1), S12–S16.
Grossman, J. H. and Galask, R. P. (1990) Persistent vaginitis caused by metronidazole resistant Trichomonas. Obstet. Gynecol. 76, 521–522.
Gupta, P. K. and Frost, J. K. (1990) Cytopathology and his-topathology of the female genital tract in T. vaginalis infection, in Trichomonads parasitic in humans (Honigberg, B. M., ed.), Springer, New York, NY, pp. 274–290.
Heine, P. and MacGregor, J. A. (1993) Trichomonas vaginalis: a re-emerging pathogen. Clin. Obstet. Gynecol. 36, 137–144.
Heyworth, P. G., Gutteridge, W. E., and Ginger, C. D. (1982) Purine metabolism in Trichomonas vaginalis. FEBS Lett. 141, 106–110.
Heyworth, P. G., Gutteridge, W. E., and Ginger, C. D. (1982) Pyrimadine metabolism in Trichomonas vaginalis. FEBS Lett. 176, 55–60.
Hipp, S. S., Kirkwood, M. W., and Hassan, H. A. (1979) Screening for Trichomonas vaginalis infection by use of acridine orange fluorescent microscopy. Sex. Transm. Dis. 6, 235–238.
Hoffmann, B., Kazanawska, W., Kilczewski, W., and Krach, J. (1963) Serologic diagnosis of Trichomonas infection. Med. Dosw. Mikrobiol. 15, 91–99.
Honigberg, B. M. (1978) Trichomonads of importance in human medicine, in Parasitic protozoa, vol. 2 (Krieger, J. P., ed.), Academic, New York, NY, pp. 275.
Honigberg, B. M. (1987) Immunology of trichomonads, with emphasis on Trichomonas vaginalis: a review. Acta Univ. Carol. Biol. 30, 321–336.
Honigberg, B. M. and King, V. M. (1964) Structure of Trichomonas vaginalis Donne. J. Parasitol. 50, 34–364.
Honigberg, B. M. and Brugerolle, G. (1990) Structure, in Trichomonads parasitic in humans (Honigberg, B. M., ed.), Springer, New York, NY, pp 5–35.
Ings, R. M., McFadzean, J. A., and Ormerod, W. E. (1974) The mode of action of metronidazole in Trichomonas vaginalis and other micro-organisms. Biochem. Pharmacol. 23, 1421–1429.
Jaakmees, H. P., Teras, J. K., Roigas, E. M., Nigeson, U. K., and Tompel, H. J. (1966) Complement fixing antibodies in the blood sera of men infested with Trichomonas vaginalis. Wiad. Parazytol. 12, 378–384.
Jirovec, O. and Petru, M. (1968) Trichomonas vaginalis and tricho-moniasis. Adv. Parasitol. 6, 117–188.
Johnson, P. J., Lahti, C. J., and Bradley, P. J. (1993) Biogenesis of the hydrogenosome in the anaerobic protest Trichomonas vagina-lis. J. Parasitol. 79, 644–670.
Kane, P. O., McFadzean, J. A., and Squires, S. (1961) Absorption and excretion of metronidazole. Part II. Studies on primary failures. Br. J. Vener. Dis. 37, 276–277.
Kerscher, L. and Oesterhelt, D. (1982) Pyruvate-ferredoxin oxi-doreductase — new findings on an ancient enzyme. Trends Biochem. Sci. 7, 371–374.
Kozlowska, D. and Wichrowska, B. (1976) The effect of chlorine and its compounds used for disinfection on Trichomonas vaginalis. Wiad. Parazytol. 22, 433–435.
Kramar, J. and Kucera, K. (1966) Immunofluorescence demonstration of antibodies in urogenital trichomoniasis. J. Hyg. Epidemiol. Microbiol. Immunol. 10, 85–88.
Krieger, J. N. (1984) Prostatitis syndromes: pathophysiology, differential diagnosis, and treatment. Sex. Transm. Dis. 11, 100–112.
Krieger, J. N. (1990) Epidemiology and clinical manifectations of urogenital trichomoniasis in men, in Trichomonads parasitic in humans (Honigberg, B. M., ed.), Springer, New York, NY, pp 235–245.
Krieger, J. N. and Rein, M. F. (1982) Zinc sensitivities of Trichomonas vaginalis: in vitro studies and clinical implications. J. Infect. Dis. 146, 341–345.
Krieger, J. N., Tam, M. R., Stevenes, C. E., Nielsen, I. O., Hale, J., Kiviat, N. B., and Holmes, K. K. (1988) Diagnosis of trichomo-niasis: comparison of conventional wet-mount examination with cytologic studies, cultures, and monoclonal antibody staining of direct specimens. JAMA 259, 1223–1227.
Krieger, J. N., Jenny, C., Verdon, M., et al. (1993) Clinical manifestations of trichomoniasis in men. Ann. Intern. Med. 188, 844–849.
Kulda, J. (1999) Trichomonads, hydrogenosomes, and drug resistance. Int. J. Parasitol. 29, 199–212.
Kulda, J., Tachezy, J., and Czerasovova, A. (1993) In vitro induces anaerobic resistance to metronidazole in Trichomonas vaginalis. J. Eukaryot. Microbiol. 40, 262–269.
Kvasnicka, W. G., Hanks, D., Huang, J. C., Hall, M. R., Sandblom, D., Chu, H. J., Chavez, L., and Acree, W. M. (1992) Clinical evaluation of the efficacy of inoculating cattle with a vaccine containing Tritrichomonas foetus. Am. J. Vet. Res. 53(11), 2023–2027.
Laga, M., Manoka, A. T., Kivuvu, M., Malele, B., Tuliza, M., Nzila, N., Goeman, J. B., Batter, F. V., Alary, M., et al. (1993) Non-ulcerative sexually transmitted diseases as risk factors to HIV-1 transmission in women: results from a cohort study. AIDS 7, 95–102.
Land, K. M., Clemens, D. L., and Johnson, P. J. (2001) Loss of multiple hydrogenosomal proteins associated with organelle metabolism and high-level drug resistance in trichomonads. Exp. Parasitol. 97, 102–110.
Land, K. M., Delgadillo-Correa, M. J., Tachezy, J., Nanacova, S., Hseih, C. L., Sutak, R., and Johnson, P. J. (2004) Targeted gene replacement of a ferredoxin gene in Trichomonas vaginalis does not lead to metronidazole resistance. Mol. Microbiol. 51(1), 115–120.
Lehker, M. W., Arroyo, R., and Aldrete, J. F. (1991) The regulation by iron of the synthesis of adhesins and cytoadherence levels in the protozoan parasite Trichomonas vaginalis. J. Exp. Med. 171, 2165–2170.
Lindmark, D. G. and Muller, M. (1976) Antitrichomonad action, mutagenicity, and reduction of metronidazole and other nitroimi-dazoles. Antimicrob. Agents Chemother. 10, 476–482.
Lindmark, D. G., Muller, M., and Shio, H. (1975) Hydrogenosomes in Trichomonas vaginalis. J. Parasitol. 61, 522–554.
Linstead, D. and Cranshaw, M. A. (1983) The pathway of arginine catabolism in the parasitic flagellate Trichomonas vaginalis. Mol. Biochem. Parasitol. 8, 241–252.
Lloyd, D. and Kristensen, B. (1985) Metronidazole inhibition of hydrogen production in vivo in drug- sensitive and -resistant strains of Trichomonas vaginalis. J. Gen. Microbiol. 131, 849–853.
Lossick, J. G. (1990) Epidemiology of urogenital trichomoniasis. Therapy of urogenital trichomoniasis, in Trichomonads parasitic in humans (Honigberg, B. M., ed.), Springer, New York, NY, pp. 324–341.
Lossick, J. G. (1990) Treatment of sexually transmitted diseases. Rev. Infect. Dis. 12(Suppl 6), S665–S681.
Lossick, J. G. and Kent, H. L. (1991) Trichomoniasis: trends in diagnosis and management. Am. J. Obstet. Gynecol. 165(4), 1217–1222.
Lossick, J. G., Muller, M., and Gorrell, T. E. (1986) In vitro drug susceptibility and doses of metronidazole required for cure in cases of refractory vaginal trichomoniasis. J. Infect. Dis. 153, 948–955.
Lushbaugh, W. B., Cleary, J. D., and Finley, R. W. (1995) Cytotoxicity of hamycin for Trichomonas vaginalis, HeLa and BHK-21. J. Antimicrob. Chemother. 36, 795–802.
Mack, S. R. and Muller, M. (1980) End products of carbohydrate metabolism in Trichomonas vaginalis. Comp. Biochem. Physiol. 67, 213–216.
Malagoli, M., Ross, T., Baggio, A., Zandomeneghi, G., Zanca, A., Casolari, C., and Castelli, M. (2002) In vitro study of chemotherapeutic activity of sulphimidazole on some sensitive and metronidazole resistant Trichomonas vaginalis strains. Pharmacol. Res. 46, 469–472.
Malla, N., Gupta, I., Sokhey, C., Sehgal, R., Ganguly, N. K., and Mahajan, R. J. (1988) In vitro evaluation of metronidazole and tinidazole on strains of Trichomonas vaginalis. Indian J. Med. Microbiol. 6, 297–301.
Martin, D. H. and Bowie, W. R. (1999) Urethritis in males, in Sexually transmitted disease, 3rd ed. (Holmes, K. K., Mardh, P. A., Sparling, P. F., and Weisner, P. J., eds.) McGraw-Hill, New York, NY, pp. 833–845.
Mason, P. R., Super, H., and Fripp, P. J. (1976) Comparison of four techniques for the routine diagnosis of Trichomonas vaginalis infection. J. Clin. Pathol. 29, 154–157.
McGrory, T. and Garber, G. E. (1992) Mouse intravaginal infection with Trichomonas vaginalis and role of Lactobacillus acidophilus in sustaining infection. Infect. Immun. 60(6), 2375–2379.
McMillan, A. (1990) Laboratory diagnostic methods and cryop-reservation of trichomonads, in Trichomonads parasitic in humans (Honigberg, B. M., ed.), Springer, New York, N Y, pp 297–310.
Meysick, K. and Garber, G. E. (1995) Trichomonas vaginalis. Curr. Opin. Infect. Dis. 8, 22–25.
Muller, M. (1986) Reductive activation of nitroimidazoles in anaerobic microorganisms. Biochem. Pharmacol. 35, 37–41.
Muresu, R., Rubino, S., Rizzu, P., Baldini, A., Colombo, M., and Capuccinelli, P. (1994) A new method for identification of Trichomonas vaginalis by fluorescent DNA in-situ hybridization. J. Clin. Microbiol. 32, 1018–1022.
Nagesha, C. W., Ananthakrishna, N. C., and Sulochana, P. (1970) Clinical and laboratory studies on vaginal trichomoniasis. Am. J. Obstet. Gynecol. 106, 933–935.
Narcisi, E. M. and Secor, W. E. (1996) In vitro effect of tinidazole and furazolidone on metronidazole-resistant Trichomonas vagina-lis. Antimicrob. Agents Chemother. 40(5), 1121–1125.
Nielson, R. (1969) Trichomonas vaginalis I: survival in solid Stuart's medium. Br. J. Vener. Dis. 45, 328–331.
O'Connor, B. H. and Adler, M. W. (1979) Current approaches to the diagnosis and reporting of trichomoniasis and candidosis. Br. J. Vener. Dis. 55, 52–57.
Perez-Reyes, E., Kalyanaraman, B., and Mason, R. P. (1980) The reductive metabolism of metronidazole and ronidazole by aerobic liver microsomes. Mol. Pharmacol. 17, 239–244.
Petrin, D., Delgaty, K., Bhatt, R., and Garber, G. E. (1998) Clinical and microbiological aspects of Trichomonas vaginalis. Clin. Micrbiol. Rev. 11(2), 300–317.
Poppe, W. A. J. (2001) Nitroimidazole resistant vaginal trichomo-niasis treated with paramomycin. Eur. J. Obstet. Gynecol. Reprod. Biol. 96, 119–120.
Rasoloson, D., Tomkova, E., Cammack, R., Kulda, J., and Tachezy, J. (2001) Metronidazole resistant strains of Trichomonas vaginalis display increased sensitivity to oxygen. Parasitology 123(1), 45–56.
Rayner, C. F. A. (1968) Comparison of culture media for the growth of Trichomonas vaginalis. Br. J. Vener. Dis. 44, 63–66.
Rein, M. F. (1977) Trichomoniasis in VD clinic women. Paper presented at the Annual Meeting of the American Public Health Association, Washington DC, November 1.
Rein, M. F. and Chapel, T. A. (1975) Trichomoniasis, candidiasis, and the minor venereal diseases. Clin. Obstet. Gynecol. 18, 73–88.
Rein, M. F. and Holmes, K. K. (1983) “Nonspecific vaginitis” vulvovaginal candidiasis and trichomoniasis: clinical features, diagnosis, and management, in Current clinical topics in infectious diseases, vol. 4 (Remington, J. S. and Swartz, M. N., eds.) McGraw-Hill, New York, NY, pp. 281–315.
Rein, M. F. and Muller, M. (1999) Trichomonas vaginalis and tri-chomiasis, in Sexually transmitted disease, 3rd ed. (Holmes, K. K., Mardh, P. A., Sparling, P. F., and Weisner, P. J., eds.) McGraw-Hill, New York, NY, pp. 481–492.
Riley, D. E., Roberts, M. C., Takayama, T., and Krieger, J. N. (1992) Development of a polymerase chain reaction-based diagnosis of Trichomonas vaginalis. J. Clin. Microbiol. 30, 465–472.
Rodgerson, E. B. (1972) Vulvovaginal papillomas and Trichomonas vaginalis. Obstet. Gynecol. 40, 327–333.
Rosa, F. W., Baum, C., and Shaw, M. (1987) Pregnancy outcomes after first-trimester vaginitis drug therapy. Obstet. Gynecol. 69(5), 751–755.
Sorvillo, F. and Kerndt, P. (1998) Trichomonas vaginalis and amplification of HIV-1 transmission. Lancet 351, 213–214.
Street, D. A., Taylor-Robinson, D., Ackers, J. P., Hanna, N. F., and McMillan, A. (1982) Evaluation of an enzyme-linked immuno-sorbent assay for the detection of antibody to Trichomonas vagina-lis in sera and vaginal secretions. B r. J. Vener. Dis. 58, 330–333.
Teras, J. K., Jaakmees, H. P., Nigeson, U. K., Roigas, E. M., and Tompel, H. J. (1966) Dependence of serologic reactions on the sero-types of Trichomonas vaginalis. Wiad. Parazytol. 12, 364–369.
Tsukahara, T. (1961) Respiratory metabolism of Trichomonas vaginalis. Jpn. J. Microbiol. 5, 157–169.
Vidakovic, M., Crossnoe, C. R., Neidre, C., Kim, K., Krause, K. L., and Germanas, J. P. (2003) Reactivity of reduced [2Fe-2S] ferredoxins parallel host susceptibility to nitroimidazoles. Antimicrob. Agents Chemother. 47(1), 302–308.
Vontver, L. A. and Eschenbach, D. A. (1981) The role of Gardnerella vaginalis in nonpesific vaginitis. Clin. Obstet. Gynecol. 24, 439–460.
Warton, A. and Honigberg, B. M. (1979) Structure of trichomonads as revealed by scanning electron microscopy. J. Protozool. 26, 5–62.
Watson, P. G. and Pattman, R. S. (1996) Arsenical pessaries in the successful elimination of metronidazole-resistant Trichomonas vaginalis. Int. J. STD AIDS 10, 277–280.
Weinberger, M. W. and Harger, J. H. (1993) Accuracy of the Papanicolaou smear in the diagnosis of asymptomatic infection with Trichomonas vaginalis. Obstet. Gynecol. 82, 425–429.
Wenrich, D. H. and Saxe, L. H. (1950) Trichomonas microti, n. sp. (Protozoa, Mastigophora). J. Parasitol. 36, 261–269.
Werness, B. A. (1989) Cytopathology of sexually transmitted diseases. Clin. Lab. Med. 9, 559.
Weston, T. E. and Nicol, C. S. (1963) Natural history of trichomo-nal infection in males. Br. J. Vener. Dis. 39, 251–257.
Whittington, M. J. (1951) The survival of Trichononas vaginalis at temperatures below 37°C. J. Hyg. 49, 400–409.
Whittington, M. J. (1957) Epidemiology of Trichomonas vagi-nalis infections in the light of improved diagnostic methods. Br. J. Vener. Dis. 33, 80–91.
Wolner-Hanssen, P., Krieger, J. N., Stevens, C. E., Kiviat, N. B., Koutsky, L., Critchlow, T., DeRouen, T., Hillier, S., and Holmes, K. K. (1989) Clinical manifestations of vaginal trichomoniasis. JAMA 261(4), 571–576.
Yarlett, N., Rowlands, C. C., Yarlett, N. C., Evans, J. C., and Lloyd, D. (1987) Reduction of niridazole by metronidazole resistant and susceptible strains of Trichomonas vaginalis. Parasitology 94, 93–99.
Yule, A., Gellan, M. C. A., Driel, J. D., et al. (1987) Detection of Trichomonas vaginalis antigen in women by enzyme immunoassay. J. Clin. Pathol. 40, 566–568.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Cudmore, S.L., Garber, G.E. (2009). Diagnosis and Treatment of Metronidazole-Resistant Trichomonas vaginalis Infection. In: Mayers, D.L. (eds) Antimicrobial Drug Resistance. Infectious Disease. Humana Press. https://doi.org/10.1007/978-1-60327-595-8_28
Download citation
DOI: https://doi.org/10.1007/978-1-60327-595-8_28
Publisher Name: Humana Press
Print ISBN: 978-1-60327-594-1
Online ISBN: 978-1-60327-595-8
eBook Packages: MedicineMedicine (R0)